Meno a priezvisko:
|
MUDr. Miriam Petrová, PhD.
|
Typ dokumentu:
|
Vedecko/umelecko-pedagogická charakteristika osoby
|
Názov vysokej školy:
|
Univerzita Komenského v Bratislave
|
Sídlo vysokej školy:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
---|---|---|
asistent | Ústav farmakológie a klinickej farmakológie, LF UK Bratislava | 2007 - 2012 |
odborný asistent | Ústav farmakológie a klinickej farmakológie, LF UK Bratislava | 2012 - doteraz |
IV.a - Popis aktivity, názov kurzu (ak išlo o kurz), iné | IV.b - Názov inštitúcie | IV.c - Rok |
---|---|---|
Using Team-Based Learning in Medical Education | Univerzita Komenského v spolupráci s lektormi z NYU | 2018 |
Kurz Team Based Learning | Ústav medicínskeho vzdelávania a simulácií LF UK | 2024 |
Kurz/workshop na vytváranie E-learningových kurzov v systéme Moodle | Ústav medicínskeho vzdelávania a simulácií LF UK | 2024 |
V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
---|---|---|---|
Farmakológia | všeobecné lekárstvo | I. + II. | všeobecné lekárstvo |
Farmakológia | zubné lekárstvo | I. + II. | zubné lekárstvo |
Klinická farmakológia | všeobecné lekárstvo | I. + II. | všeobecné lekárstvo |
V3 Petrová M, Laššánová M, Tisoňová J, Líšková S. Ca2+-Dependent Cl- Channels in Vascular Tone Regulation during Aging. International journal of molecular sciences 2024, 25 (10): 5093. (2023: 4.9 – IF, 1.179 – JCR)
V3 Wawruch M, Petrova M, Tesar T, Murin J, Schnorrerova P, Paduchova M, Celovska D, Havelkova B, Trnka M, Alfian SD, Aarnio E. Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease. Front Pharmacol. 2023; 14: 1199669. (2022: 5.6 – IF, Q1 – JCR, Q1 – SJR)
ADC Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Matalova P, Havelkova B, Trnka M, Aarnio E. Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease. Biomedicines. 2021; 9 (12): 1800. (2020: 6.081 – IF, Q1 – JCR, Q1 – SJR)
ADC Líšková S, Petrová M, Karen P, Kuneš J, Zicha J. Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. Eur J Pharmacol. 2011;667 (1-3):265-70. (2010: 2.737 – IF, Q2 – JCR, Q2 – SJR)
ADC Behuliak M, Pintérová M, Bencze M, Petrová M, Líšková S, Karen P, Kuneš J, Vaněčková I, Zicha J. Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 2013; 31 (10):2025-35. (2012: 3.806 – IF, Q1 – JCR, Q1 – SJR)
ADC Dobiaš L, Petrová M, Vojtko R, Uličná O, Vančová O, Kristová V. Effect of sulodexide on vascular responses and liver mitochondrial function in diabetic rats. Physiol Res. 2015; 64 (Suppl 4): S497-505. (2014: 1.293 – IF, Q4 – JCR, Q2 – SJR)
V3 Petrová M, Laššánová M, Tisoňová J, Líšková S. Ca2+-Dependent Cl- Channels in Vascular Tone Regulation during Aging. International journal of molecular sciences 2024, 25 (10): 5093. (2023: 4.9 – IF, 1.179 – JCR)
V3 Wawruch M, Petrová M, Čelovská D, Alfian SD, Tesař T, Murín J, Trnka M, Padúch T, Aarnio E. Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients. Frontiers in Pharmacology 2024, 15: 1464689. (2023: 4.4 – IF, 1,066 – SJR)
V3 Wawruch M, Murin J, Tesar T, Petrova M, Paduchova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines. 2023; 11 (2): 368. (2022: 4.7 – IF, Q2 – JCR, Q1 – SJR)
V3 Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease. Biomedicines. 2022; 10 (7):1479. (2021: 4.757 – IF, Q2 – JCR, Q1 –SJR)
V3 Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Aarnio E. Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease. Biomedicines. 2021; 9 (9): 1280. (2020: 6.081 – IF, Q1 – JCR, Q1 – SJR)
ADC Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Aarnio E. Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease. Front Pharmacol. 2021; 12: 687549. (2020: 5.811 – IF, Q1 – JCR, Q1 – SJR)
ADC Wawruch M, Wimmer G, Murín J, Paduchová M, Petrová M, Tesař T, Matalová P, Havelková B, Trnka M, Aarnio E. Non-adherence to statin treatment in older patients with peripheral arterial disease depending on persistence status. Biomedicines. 2020; 8 (10): 378. (2019: 4.717 – IF, Q1 – JCR, Q1 – SJR)
V3 Wawruch M, Murin J, Tesar T, Petrova M, Paduchova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines. 2023; 11 (2): 368. cit.: [n1] 2024 Piechocki, M. - Przewlocki, T. - Pieniazek, P. - Trystula, M. - Podolec, J. - Kablak-Ziembicka, A. : A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review PART II-Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory. In: Journal of Clinical Medicine, vol. 13, no. 5, 2024. art. no. 1508 - SCI ; SCOPUS
ADC Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Matalova P, Havelkova B, Trnka M, Aarnio E. Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease. Biomedicines. 2021; 9 (12): 1800. cit: [n1] 2022 zz ~ Bhagirath, V.C. - Nash, D. - Wan, D. - Anand, S.S.: Canadian Journal of Cardiology, vol. 38, no. 5, 2022, s. 634-644 -- SCI ; SCOPUS
ADC Behuliak M, Pintérová M, Bencze M, Petrová M, Líšková S, Karen P, Kuneš J, Vaněčková I, Zicha J. Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 2013; 31 (10):2025-35. cit: [o1] 2014 ~ Mizuno, M. - Iwamoto, G.A. - Vongpatanain, W. - Mitchell, J.H. - Smith, S.A.: American Journal of Physiology - Heart and Circulatory Physiology, vol. 307, no. 2, 2014, s. H242-H251 -- SCI ; SCOPUS
ADC Líšková S, Petrová M, Karen P, Kuneš J, Zicha J. Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. Eur J Pharmacol. 2011; 667 (1-3):265-70. cit. [o1] 2019 ~ Paz, A.A. - Arenas, G.A. - Castillo-Galán, S. - Penaloza, E. - Cáceres-Rojas, G. - Suazo, J. - Herrera, E.A. - Krause, B.J.: International Journal of Molecular Sciences, vol. 20, no. 14, 2019, art. no. 3474 -- SCI ; SCOPUS
ADC Lísková S, Petrová M, Karen P, Kunes J, Zicha J. Influence of calcium-dependent potassium channel blockade and nitric oxide inhibition on norepinephrine-induced contractions in two forms of genetic hypertension. J Am Soc Hypertens. 2010; 4 (3):128-34. cit. [o1] 2021 ~ Matsumoto, T. - Takayanagi, K. - Katome, T. - Kojima, M. - Taguchi, K. - Kobayashi, T.: Pharmacology, vol. 106, no. 7-8, 2021, s. 435-445 -- SCI ; SCOPUS
2021-2024 Vedecká grantová agentúra Ministerstva škostva, vedy, výskumu a športu SR - VEGA 1/0024/21 (spoluriešiteľ) "Možnosti farmakoepidemiologickej analýzy adherencie k preventívnej farmakoterapii u starších pacientov s periférnym artériovým ochorením dolných končatín"
2017-2019 Vedecká grantová agentúra Ministerstva škostva, vedy, výskumu a športu SR - VEGA 1/0112/17 (spoluriešiteľ) "Adherencia k farmakoterapii – základný predpoklad úspešnosti sekundárnej prevencie kardiovaskulárnych ochorení u starších ľudí"
2021 - 2023 Európsky fond regionálneho rozvoja – No. 313011AVG3 – (spoluriešiteľ) "Vývoj biomodelov pre zlepšenie hodnotenia
účinnosti liekov a látok, ktoré majú potenciál pri liečbe COVID-19 (BIOVID-19)"
VIII.a - Názov inštitúcie | VIII.b - Sídlo inštitúcie | VIII.c - Obdobie trvania pôsobenia/pobytu (uviesť dátum odkedy dokedy trval pobyt) | VIII.d - Mobilitná schéma, pracovný kontrakt, iné (popísať) |
---|---|---|---|
Česká akadémia vied, Fyziologický Ústav | Vídeňská 1083, 142 00 Praha 4 | leto 2009, leto 2010, leto 2011 | odborná stáž |